Background/Aim
The use of stress cardiac magnetic resonance (CMR) as a clinical tool to evaluate myocardial ischaemia has increased significantly over recent years, but large-scale audit data is lacking. We therefore aimed to assess the tolerance, safety and accuracy of stress CMR in routine clinical practice.
Methods
We retrospectively examined all stress CMR studies performed at our tertiary referral centre over a 20-month period, since the service was started in 2007. Patients were scanned in a 1.5T magnet (Avanto, Siemens), using a standardised protocol with routine imaging for late gadolinium enhancement (LGE). They were screened for contraindications to adenosine, and routine anti-anginal therapies, including beta-blockers, were not discontinued. Dobutamine stress was given in small number of patients in whom adenosine was contraindicated. Angiograms of patients who also had cardiac catheterization within 6 months of their CMR scan, were reassessed by an interventional cardiologist, blinded to the CMR data. For receiver-operator curve (ROC) analysis, CMR stress perfusion defects were graded into 5 categories (normal, probably normal, possibly abnormal, probably abnormal, abnormal).
Results
A total of 654 patients were scanned. The mean age was 65 ± 29 years, and there were 63 inpatients (9.6%). The majority (639 patients; 97.7%) received intravenous adenosine (140mcg/kg/min for average of 3 minutes), 10 received intravenous dobutamine and 5 patients had both. Of the 15 patients who received dobutamine, 12 had no side effects/complications, 2 experienced nausea, and 1 chest tightness. Tolerance and safety data for all 644 patients who received adenosine are shown in Table 1. 241 patients also had coronary angiography. ROC analysis for detecting significant stenoses of >70% is shown in figure 1.
Conclusion
We conclude that stress CMR, with adenosine as the main stress agent, is well-tolerated, safe and accurate in routine clinical practice.
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University Hospitals of Leicester NHS Trust, Leicester, UK Table 1 No. % Minor symptoms (e.g. mild chest pain, breathlessness) 285 43
Number of patients where adenosine was discontinued prematurely Submit your manuscript at www.biomedcentral.com/submit Figure 1 The area under curve (AUC) is 0.91± 0.02, with a prevalence of 71%. The overall sensitivity is 91%, specificity 86%, and accuracy 90%. These results compare very favourably with previous smaller research studies and meta-analyses.
